Skip to content
devi
CERTS
Devices
Categories
Manufacturers
Importers
Certifiers
Authorities
Reps.
Representatives
Categories
/
Implantable prosthetic and osteosynthesis devices
/
Respiratory prostheses
/
Tracheobronchial prostheses
Tracheobronchial prostheses
P0401
642 devices
HEX14-50
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
HEX13-30
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
SG16-70
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
SG10-40
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
TM15
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
CLASSX10-50
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
SAPX13-70
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
SYOX08-6
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
SGX13-80
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
SAP17-50
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
Hanarostent®
M.I.Tech Co., Ltd.
·
,
South Korea
Class IIb
CE/MDD
SAP14-50
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
STX13-30
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
TM18
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
Tracheobronxane Dumon
Novatech SA
·
,
France
Class IIb
FDA 510(k)
K243126
Active
Cleared 29 Oct 2024
CE/MDD
+1
authorizations
TMPAX7
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
STX08-50
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
Hanarostent®
M.I.Tech Co., Ltd.
·
,
South Korea
Class IIb
CE/MDD
HEX18-40
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
CLASSX13-30
Animus Beyford Trading Sl
·
,
Spain
Class IIb
CE/MDR
×2
Active
Valid to Jun 2030
Previous
Next